Cytochrome P450 F3 promotes colorectal cancer via inhibiting NRF2-mediated ferroptosis.
Ontology highlight
ABSTRACT: Cytochrome P450 F3 (CYP4F3) is recognized as a disease-associated immune response initiator that is involved in the synthesis of cholesterol, steroids, and lipids. This study identified the upregulation of CYP4F3 expression in colorectal cancer (CRC) and its association with poor patient prognosis through a comparative analysis between CRC tumor tissues with normal tissues from public databases. The overexpression of CYP4F3 in CT26.wt and SW620, promoted cell proliferation and migration, a reduction of cellular oxidative stress, an up-regulation of the oxidative stress-related pathway NRF2, and an inhibition of cellular ferroptosis. Additionally, inhibition of NRF2 activity stimulated cellular ferroptosis when CYP4F3 was overexpressed. Ferroptosis, characterized by iron-dependent lipid per
SUBMITTER: Xu Z
PROVIDER: S-EPMC11357859 | biostudies-literature | 2024 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA